Patents by Inventor Noel Yves Henri Jean Genin

Noel Yves Henri Jean Genin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240042037
    Abstract: The present invention relates to novel stable compressed vaccine composition comprising at least one anhydrous antigenic component comprising a stabilizer susceptible to foaming when the composition is mixed with liquid diluent; and an effective amount of a sugar alcohol.
    Type: Application
    Filed: October 9, 2023
    Publication date: February 8, 2024
    Applicant: Abic Biological Laboratories Ltd.
    Inventor: Noel Yves Henri Jean Genin
  • Patent number: 11813322
    Abstract: The present invention relates generally to the fields of immunology and vaccine technology. More specifically, the present invention relates to stabilized liquid immunogenic compositions and vaccines having a live attenuated viral antigen, and methods of using the same. The live attenuated viral antigen can be a live peste des petits ruminants (PPR) virus.
    Type: Grant
    Filed: June 5, 2020
    Date of Patent: November 14, 2023
    Inventors: Noel Yves Henri Jean Genin, David Pierre Corneille, Bradley Eddy
  • Publication number: 20220241421
    Abstract: The present invention relates to novel stable compressed vaccine composition comprising at least one anhydrous antigenic component comprising a stabilizer susceptible to foaming when the composition is mixed with liquid diluent; and an effective amount of a sugar alcohol.
    Type: Application
    Filed: January 21, 2022
    Publication date: August 4, 2022
    Applicant: Abic Biological Laboratories Ltd.
    Inventor: Noel Yves Henri Jean Genin
  • Publication number: 20200384101
    Abstract: The present invention relates generally to the fields of immunology and vaccine technology. More specifically, the present invention relates to stabilized liquid immunogenic compositions and vaccines having a live attenuated viral antigen, and methods of using the same. The live attenuated viral antigen can be a live peste des petits ruminants (PPR) virus.
    Type: Application
    Filed: June 5, 2020
    Publication date: December 10, 2020
    Inventors: Noel Yves Henri Jean Genin, David Pierre Corneille, Bradley Eddy
  • Publication number: 20200188519
    Abstract: The present invention relates to novel stable compressed vaccine composition comprising at least one anhydrous antigenic component comprising a stabilizer susceptible to foaming when the composition is mixed with liquid diluent; and an effective amount of a sugar alcohol.
    Type: Application
    Filed: February 26, 2020
    Publication date: June 18, 2020
    Applicant: Abic Biological Laboratories Ltd.
    Inventor: Noel Yves Henri Jean Genin
  • Patent number: 10653627
    Abstract: The present invention relates generally to the fields of immunology and vaccine technology. More specifically, the present invention relates to methods for vitrifying biological preparations, including peptides, antigens, antibodies, cells, and the like.
    Type: Grant
    Filed: November 7, 2018
    Date of Patent: May 19, 2020
    Assignee: BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.
    Inventor: Noel Yves Henri Jean Genin
  • Patent number: 10632182
    Abstract: The present invention relates generally to the fields of immunology and vaccine technology. More specifically, the present invention relates to methods for freeze-drying biological preparations, including peptides, antigens, antibodies, and especially, cells. Importantly, the disclosed methods preserve the viability, infectivity and immunogenicity of cells from the Apicomplexa phylum, the Sarcocystidae family, and in particular, cells from the Toxoplasma genus.
    Type: Grant
    Filed: May 13, 2015
    Date of Patent: April 28, 2020
    Inventors: Noel Yves Henri Jean Genin, Jean-Christophe Audonnet, Didier Roy, Edouard Seche, Patrick Gervais, Samira Khaldi-Plassart, Romain Useo, Joelle DeConinck
  • Patent number: 10610596
    Abstract: Disclosed and claimed are methods for making solid vaccine compositions that have reduced foaming when mixed with liquid diluent. The methods include mixing an effective amount of a foam controlling agent with at least one anhydrous antigenic component, a stabilizer, and an effervescent agent. The foam controlling agent is a sugar alcohol, such as mannitol. The effective amount of sugar alcohol is about 15% to about 40% by weight of the solid vaccine composition. And, upon adding a diluent to the solid vaccine composition, the effervescent agent reacts to form gas in situ, and foam resulting from the gas is reduced.
    Type: Grant
    Filed: January 24, 2019
    Date of Patent: April 7, 2020
    Assignee: Abic Biological Laboratories Ltd.
    Inventor: Noel Yves Henri Jean Genin
  • Publication number: 20190151451
    Abstract: The present invention relates to novel stable compressed vaccine composition composing at least one anhydrous antigenic component comprising a stabilizer susceptible to foaming when the composition is mixed with liquid diluent; and an effective amount of a sugar alcohol.
    Type: Application
    Filed: January 24, 2019
    Publication date: May 23, 2019
    Inventor: Noel Yves Henri Jean Genin
  • Publication number: 20190070117
    Abstract: The present invention relates generally to the fields of immunology and vaccine technology. More specifically, the present invention relates to methods for vitrifying biological preparations, including peptides, antigens, antibodies, cells, and the like.
    Type: Application
    Filed: November 7, 2018
    Publication date: March 7, 2019
    Applicant: Merial, Inc.
    Inventor: Noel Yves Henri Jean Genin
  • Patent number: 10213509
    Abstract: The present invention relates to novel stable compressed vaccine composition comprising at least one anhydrous antigenic component comprising a stabilizer susceptible to foaming when the composition is mixed with liquid diluent; and an effective amount of a sugar alcohol.
    Type: Grant
    Filed: September 10, 2018
    Date of Patent: February 26, 2019
    Assignee: MERIAL INC.
    Inventor: Noel Yves Henri Jean Genin
  • Patent number: 10188734
    Abstract: The present invention relates to novel stable compressed vaccine composition comprising at least one anhydrous antigenic component comprising a stabilizer susceptible to foaming when the composition is mixed with liquid diluent; and an effective amount of a sugar alcohol.
    Type: Grant
    Filed: October 9, 2015
    Date of Patent: January 29, 2019
    Assignee: MERIAL, INC.
    Inventor: Noel Yves Henri Jean Genin
  • Publication number: 20190000978
    Abstract: The present invention relates to novel stable compressed vaccine composition comprising least one anhydrous antigenic component comprising a stabilizer susceptible to foaming when the composition is mixed with liquid diluent; and an effective amount of a sugar alcohol.
    Type: Application
    Filed: September 10, 2018
    Publication date: January 3, 2019
    Inventor: Noel Yves Henri Jean Genin
  • Patent number: 10166188
    Abstract: The present invention relates generally to the fields of immunology and vaccine technology. More specifically, the present invention relates to methods for vitrifying biological preparations, including peptides, antigens, antibodies, cells, and the like.
    Type: Grant
    Filed: May 31, 2012
    Date of Patent: January 1, 2019
    Assignee: MERIAL, INC.
    Inventor: Noel Yves Henri Jean Genin
  • Publication number: 20170087230
    Abstract: The present invention relates generally to the fields of immunology and vaccine technology. More specifically, the present invention relates to methods for freeze-drying biological preparations, including peptides, antigens, antibodies, and especially, cells. Importantly, the disclosed methods preserve the viability, infectivity and immunogenicity of cells from the Apicomplexa phylum, the Sarcocystidae family, and in particular, cells from the Toxoplasma genus.
    Type: Application
    Filed: May 13, 2015
    Publication date: March 30, 2017
    Applicants: MERIAL INC., VITAMFERO S.A, L'Universite De Bourgogne, L'Institut National Superieur des Sciences Agronom iques de L'Alimentation et de L'Environment
    Inventors: Noel Yves Henri Jean Genin, Jean-Christophe Audonnet, Didier Roy, Edouard Seche, Patrick Gervais, Samira Khaldi-Plassart, Romain Useo, Joelle DeConinck
  • Publication number: 20160256554
    Abstract: The present invention relates to novel stable compressed vaccine composition comprising at least one anhydrous antigenic component comprising a stabilizer susceptible to foaming when the composition is mixed with liquid diluent; and an effective amount of a sugar alcohol.
    Type: Application
    Filed: October 9, 2015
    Publication date: September 8, 2016
    Applicant: MERIAL INC.
    Inventor: Noel Yves Henri Jean Genin
  • Patent number: 8784843
    Abstract: The present invention relates generally to the fields of immunology and vaccine technology. More specifically, the present invention relates to stabilizers for freeze-dried live attenuated immunogenic and/or vaccine compositions, which may comprise, inter alia, canine paramyxovirus. The invention further relates to stabilized, freeze-dried live attenuated immunogenic and/or vaccine compositions of, for example, canine paramyxovirus, which may contain these stabilizers. Other aspects of the invention are described in or are obvious from the following disclosure, and are within the ambit of the invention.
    Type: Grant
    Filed: September 15, 2006
    Date of Patent: July 22, 2014
    Assignee: Merial Limited
    Inventors: Delphine Magali Belin-Poput, Noel Yves Henri Jean Genin
  • Publication number: 20130040370
    Abstract: The present invention relates generally to the fields of immunology and vaccine technology. More specifically, the present invention relates to methods for vitrifying biological preparations, including peptides, antigens, antibodies, cells, and the like.
    Type: Application
    Filed: May 31, 2012
    Publication date: February 14, 2013
    Inventor: Noel Yves Henri Jean Genin